This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

5 Under-$10 Stocks Primed to Trade Higher

Traders can look to buy ACAD off weakness as long as it's trending above some near-term support levels at $4.62 a share or even $4.17 a share. I would use a stop that sits just below those levels. You can also buy off strength once ACAD takes out those breakout levels with volume and then simply use a stop that sits near $4.62 a share.

Mitel Networks

Another under-$10 stock that's quickly moving within range of triggering a near-term breakout trade is Mitel Networks (MITL), which is a provider of integrated communications solutions focused on the small-to-medium sized enterprise market. This stock has been trending higher during the last three months, with shares up just over 20%.

If you take a look at the chart for Mitel Networks, you'll notice that this stock recently bounced strongly right off its 50-day moving average of $2.81 a share. That bounce is quickly pushing shares of MITL within range of triggering a near-term breakout trade and within range of taking out its 200-day moving average of $3.55 a share.

Market players should now look for long-biased trades in MITL once it breaks out above some near-term overhead resistance at its 200-day of $3.55 and then above some more overhead resistance at $3.61 a share with high volume. Look for a sustained move or close above those levels with volume that registers near or above its three-month average action 38,423 shares.

Traders can look to buy MITL off any weakness as long as it's trending above some near-term support levels at $3 to $2.81 a share. I would simply use a stop that sits right below $3 or $2.81 if you buy off weakness. One can also buy off strength if MITL clears those breakout levels with volume and then simply use a stop that sits right around $3.20 a share.


One under-$10 name that's trending very close to triggering a major breakout trade is NuPathe (PATH), which is a biopharmaceutical company focused on the development and commercialization of branded therapeutics for diseases of the central nervous system, including neurological and psychiatric disorders. This stock has been blazing a trail to the upside so far in 2012, with shares up 89%.

3 of 6

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,156.85 +24.88 0.15%
S&P 500 2,001.57 +2.59 0.13%
NASDAQ 4,562.1890 +9.43 0.21%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs